Surgical platform UltraGreen targets Asia for growth
Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market
[SINGAPORE] Medical procedures can be risky. One company is providing data that could help reduce complications from surgery.
Now, with Singapore in the centre of its plans, UltraGreen is looking to tap the sizeable Asian market for growth.
The company’s fluorescent dye and artificial intelligence (AI) platform gives surgeons an “inside look” into living tissue, by measuring and monitoring blood flow in the human tissue.
TRENDING NOW
DBS, OCBC, UOB rout lops billions off STI as inflation, rate concerns spook investors
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
OCBC sheds S$8 billion in value as shares close nearly 6% down; analysts cautious on banks
Deal between tycoon friends sparks scrutiny of Philippine power sector